The National Institute on Aging's 2026 Dementia Care and Caregiving Research Summit found that researchers still cannot reliably compare care outcomes across dementia subtypes. The 2026 Dementia Care and Caregiving Research Summit Report names Alzheimer's disease as the best-documented form of dementia, while frontotemporal dementia (FTD) and Lewy body dementia remain understudied alongside the caregivers who support them. That gap matters because the summit also found that dementia caregivers already "report higher burdens, fewer rewards, and more life changes due to caregiving than other caregivers," according to the summit's program book. Families managing a less-common subtype are carrying that load with less research behind them.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the NIA's 2026 report actually found
- Why studies can't be compared across dementia types
- Why caregivers of rarer subtypes are hard to find for research
- What this means if you're caring for someone with FTD or Lewy body dementia
- The broader push behind these findings
- Frequently Asked Questions
What the NIA's 2026 report actually found
The report states a need for "data that includes validated measures to capture dementia sub-type and/or their defining characteristics (such as symptoms or biological markers)," so that care research can be compared across subtypes, according to the summit report. In plain terms: most existing caregiving studies don't consistently record which type of dementia a care recipient has, or how it was diagnosed, which makes it hard to know whether a finding from one study applies to another family's situation. The report separately flags research on "small subpopulations, such as adolescent caregivers and people with non-Alzheimer's dementias (e.g., FTD, Lewy body dementia)," as an area needing better data integration, per the same report. FTD causes changes in behavior, personality, or language, often starting before age 65.
Lewy body dementia causes fluctuating cognition, visual hallucinations, and movement symptoms. Both are named explicitly as underrepresented in the caregiving evidence base. A companion report from NIH confirms this extends beyond caregiving research into disease detection itself: "important gaps remain, especially for dementias other than Alzheimer's, to detect these diseases early, before symptoms appear," states the 2026 NIH Alzheimer's Disease and Related Dementias Research Progress Report. Non-Alzheimer's dementias lag behind not just in caregiving data, but in the basic science of early detection.
Why studies can't be compared across dementia types
Even when subtype data exists, it's often unusable for comparison. The summit report notes that "data sources often use different measure definitions, and even subtle differences in measures prevent crosswalk across datasets," according to the report. One study might define "caregiver burden" differently from another, so results can't be lined up side by side even when both studied the same dementia subtype.
This is a measurement problem, not just a missing-data problem. Two research teams studying Lewy body dementia caregivers, for instance, could use different survey instruments and produce findings that look contradictory simply because they measured different things. The report treats this as a priority to fix before subtype-specific conclusions can be trusted.
Why caregivers of rarer subtypes are hard to find for research
Part of the gap traces back to a basic logistical problem: identifying family caregivers in the first place. The report names identifying care partners through medical records as "challenging," citing the NIA IMPACT Collaboratory's work on this issue, according to the summit report. Medical records are typically built around the patient, not the person caring for them, so there's no reliable administrative trail to recruit caregivers for a study.
That problem compounds for rarer subtypes. If FTD and Lewy body dementia already represent a smaller share of diagnoses, and caregivers for any subtype are hard to locate through records, then caregivers of less common subtypes end up doubly hard to reach. Fewer of them are found, and fewer of those who are found are recorded with enough detail to analyze by subtype.
What this means if you're caring for someone with FTD or Lewy body dementia
The summit report lists remaining gaps in dementia care navigation research as data on program components, caregiver outcomes, economic impact, effectiveness across populations and care settings, and long-term impacts, per the report. None of this is yet broken out reliably by dementia subtype, which has a direct practical consequence: caregivers of people with FTD or Lewy body dementia should expect less tailored guidance and fewer subtype-matched support resources than families managing Alzheimer's disease specifically, according to the same report.
This doesn't mean no resources exist. It means that when you read a caregiving study, support program evaluation, or outcome statistic, check whether it specifies the dementia subtype it studied. A statistic drawn mostly from Alzheimer's caregivers may not transfer cleanly to the behavioral challenges of FTD or the fluctuating symptoms of Lewy body dementia.
- Ask any program, support group, or study you consider joining whether it tracks or targets a specific dementia subtype.
- Treat general "dementia caregiver" statistics as most reliable for Alzheimer's disease, since that is where the evidence base is deepest.
- If you care for someone with FTD or Lewy body dementia, look for organizations built specifically around that subtype, since general dementia resources were shaped disproportionately by Alzheimer's-focused data.
The broader push behind these findings
This data gap isn't an isolated observation. It follows a broader federal effort to examine who dementia research represents and who it leaves out.
A 2024 NIA Request for Information (NOT-AG-24-086) sought public input to update the agency's Health Disparities Research Framework, feeding into the kind of scrutiny that produced the 2026 summit's findings, according to NIH's notice. The summit, held March 17–19, 2026, represents a continuation of that effort specifically applied to dementia subtypes and caregiving.
Frequently Asked Questions
Does the NIA's 2026 report mean no research exists on FTD or Lewy body dementia caregiving?
No. It means existing studies rarely use matching definitions or validated subtype measures, so findings are hard to compare or generalize across datasets, per the summit report.
Why are caregivers of rarer dementia subtypes harder to study?
Identifying any family caregiver through medical records is already difficult, according to the report, and that problem is magnified for smaller subtype populations like FTD and Lewy body dementia.
Where should I look for subtype-specific caregiving guidance?
Seek organizations and programs that explicitly name the subtype you're dealing with, since general dementia caregiving data skews toward Alzheimer's disease, per the summit report.
You Might Also Like
- Privacy and Data Access Gaps in 2026 Dementia Research: Who Was Studied and Who Was Not for Family Caregivers
- CMS GUIDE Dementia Care Payment Changes in 2026: Questions Family Caregivers Can Ask a Provider
- The House Passage of the AADAPT Dementia Training Act in 2026: Questions Medicare Families Can Ask a Provider
